Clinical Trials Sponsored by Windtree Therapeutics
Total 6296 results
-
Windtree TherapeuticsTerminatedRespiratory Distress Syndrome, NewbornPoland
-
Windtree TherapeuticsCompleted
-
Windtree TherapeuticsTerminatedRespiratory Distress SyndromeCanada, United States, Chile, Poland
-
Windtree TherapeuticsTerminatedMeconium AspirationUnited States
-
Windtree TherapeuticsCompletedCOVID-19 | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)United States, Argentina
-
Windtree TherapeuticsCompletedRespiratory Distress SyndromeUnited States, Canada, Colombia, Hungary, Chile, Ireland, Netherlands, Poland
-
Windtree TherapeuticsTerminated
-
Windtree TherapeuticsTerminatedRespiratory Distress SyndromeUnited States
-
Windtree TherapeuticsTerminatedPremature Birth | Respiratory Distress Syndrome, Newborn | Bronchopulmonary DysplasiaUnited States
-
Windtree TherapeuticsCompletedAcute Hypoxemic Respiratory FailureUnited States, Chile
-
Windtree TherapeuticsCVie Therapeutics Co. Ltd.CompletedAcute Decompensated Heart FailureChina, Italy
-
Windtree TherapeuticsMomentum Research, Inc.Not yet recruiting
-
Windtree TherapeuticsMomentum Research, Inc.Active, not recruitingCardiogenic ShockUnited States, Italy, Poland, Argentina
-
Children's Hospitals and Clinics of MinnesotaWindtree TherapeuticsSuspendedRespiratory Distress SyndromeUnited States
-
Windtree TherapeuticsNational Heart, Lung, and Blood Institute (NHLBI)CompletedRespiratory Distress SyndromeUnited States
-
University of North Carolina, Chapel HillWindtree Therapeutics; Cystic Fibrosis FoundationCompletedCystic FibrosisUnited States
-
TheratechnologiesPPD; Syneos Health; Windtree Therapeutics; Innovaderm Research Inc.; Altasciences...RecruitingSolid Tumor | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Small-cell Lung Cancer | Thyroid Cancer | Cutaneous Melanoma | TNBC - Triple-Negative Breast Cancer | Hormone Receptor-positive Breast Cancer | SORT1+ CancersUnited States, Canada
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
CRISPR Therapeutics AGActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Canada, Netherlands
-
APRINOIA Therapeutics, LLCActive, not recruitingAlzheimer Disease | Tauopathies | Healthy VolunteersUnited States
-
CRISPR Therapeutics AGRecruitingClear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal CarcinomaUnited States
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Celsus Therapeutics PLCTerminatedAtopic DermatitisIsrael
-
CRISPR Therapeutics AGRecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)United States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States, Australia
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States
-
Skyline Therapeutics (US) Inc.RecruitingNeovascular Age-related Macular DegenerationChina, United States
-
iCell Gene TherapeuticsiCar Bio TherapeuticsRecruitingRelapsed/Refractory, High Risk Hematologic Malignancies | T-ALL/LymphomaChina
-
Arthrosi TherapeuticsRecruitingHyperuricemia | Gout | Arthritis, Gouty | Gout ChronicUnited States, Australia, New Zealand
-
Quanta TherapeuticsNot yet recruitingAdvanced Solid Tumor
-
Neurona TherapeuticsNot yet recruitingEpilepsy, Temporal Lobe
-
Highlight TherapeuticsRecruitingBasal Cell CarcinomaIsrael
-
Aliada TherapeuticsNot yet recruitingAlzheimer DiseaseUnited States
-
Tisento TherapeuticsNot yet recruitingMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)United States, Australia, Italy, Germany, Canada, United Kingdom
-
Kyverna TherapeuticsNot yet recruitingSystemic Sclerosis | Systemic Sclerosis - Diffuse Cutaneous | Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
-
Eilean TherapeuticsRecruiting
-
United TherapeuticsNot yet recruitingPulmonary Hypertension | Interstitial Lung Disease | Pulmonary Hypertension Due to Lung Diseases and Hypoxia
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
Eilean TherapeuticsNot yet recruiting
-
Skyline TherapeuticsRecruitingNeovascular (Wet) Age-related Macular DegenerationChina, United States
-
Starna TherapeuticsNot yet recruitingRespiratory Syncytial Virus Infections
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Nektar TherapeuticsRecruiting
-
Cybrexa TherapeuticsNot yet recruitingPlatinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma